January 2017

Editorial: Steve McIver, EditorAdvertising: Maureen Dwyer Liberti, Vice President, Group PublisherProduction: Dawn Flook, Director of Production ServicesCirculation: Jackie Ott, Circulation ManagerWebmaster: Webmaster … read more at: https://www.ptcommunity.com/wire/gw-pharmaceuticals-report-q1-financial-results-and-host-conference-call-7-february-2017

by

Marijuana Ingredient Shows Promise in Seizure Reduction While many states across our nation are engaged in political battles over the recreational use of marijuana, researchers have been busy studying the medical benefits of cannabidiol.   Pharmacist Education Clinical features with downloadable PDFs   … read more at: http://www.pharmacytimes.com/publications/issue/2016/october2016/r773_october2016

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title,85,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary,iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://wcfcourier.com/news/opinion/editorial/iowa-should-expand-medical-marijuana-program/article_2a358420-73c9-5a59-bf90-5dd83a72a9d8.html

by

Editorial: Steve McIver, EditorAdvertising: Maureen Dwyer Liberti, Vice President, Group PublisherProduction: Dawn Flook, Director of Production ServicesCirculation: Jackie Ott, Circulation ManagerWebmaster: Webmaster … read more at: https://www.ptcommunity.com/wire/gw-pharmaceuticals-report-q1-financial-results-and-host-conference-call-7-february-2017

by

Whenever Ashley Miller posts new content, you’ll get an email delivered to your inbox with a link. Email notifications are only sent once a day, and only if there are new matching items. … read more at: http://globegazette.com/news/iowa/iowa-mom-takes-son-off-cannabis-oil-says-it-doesn/article_2db6d26a-869f-51fc-b24a-2d1211fbc052.html

by

LONDON, Jan. 30, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 7 February, 2017 its first quarter financial results for the period ending 31 December, 2016. GW will also host a […]

by

Whenever Erin Murphy posts new content, you’ll get an email delivered to your inbox with a link. Email notifications are only sent once a day, and only if there are new matching items. … read more at: http://wcfcourier.com/news/local/govt-and-politics/families-wait-watch-future-of-medical-marijuana-laws/article_0408774a-2d28-5082-9874-bd7b0d0f4351.html

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title,85,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary,iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://siouxcityjournal.com/news/local/families-wait-as-iowa-lawmakers-consider-future-of-medical-marijuana/article_94f88550-c52e-545b-b224-cd69b722abfe.html

by

Paul Armentano | January 26, 2017 DERBY, UK — The administration of THCV (tetrahydrocannabivarin), a non-psychoactive component of cannabis, is positively associated with glycemic control in type 2 diabetics, according to the randomized, placebo-controlled data published in the journal Diabetes Care. Investigators from the University of Nottingham, School of Medicine assessed the twice daily administration of […]

by

Following up on an eventful 2016, this year brings plenty of value-creating events for marijuana stocks. Here’s what to look for with Insys Therapeutics (NASDAQ:INSY), GW Pharmaceuticals (NASDAQ:GWPH) and Corbus Pharmaceuticals Holdings (NASDAQ:CRBP). Image source: Getty Images. Schedule this Last July, Insys Therapeutics gained approval from the Food and Drug Administration for Syndros, its pharmaceutical […]

by

Following up on an eventful 2016, this year brings plenty of value-creating events for marijuana stocks. Here’s what to look for with Insys Therapeutics (NASDAQ:INSY), GW Pharmaceuticals (NASDAQ:GWPH) and Corbus Pharmaceuticals Holdings (NASDAQ:CRBP). Image source: Getty Images. Schedule this Last July, Insys Therapeutics gained approval from the Food and Drug Administration for Syndros, its pharmaceutical […]

by

Following up on an eventful 2016, this year brings plenty of value-creating events for marijuana stocks. Here’s what to look for with Insys Therapeutics (NASDAQ: INSY), GW Pharmaceuticals (NASDAQ: GWPH) and Corbus Pharmaceuticals Holdings (NASDAQ: CRBP). Continue Reading Below Image source: Getty Images. Schedule this Last July, Insys Therapeutics gained approval from the Food and […]

by

Following up on an eventful 2016, this year brings plenty of value-creating events for marijuana stocks. Here’s what to look for with Insys Therapeutics (NASDAQ: INSY), GW Pharmaceuticals (NASDAQ: GWPH) and Corbus Pharmaceuticals Holdings (NASDAQ: CRBP). Continue Reading Below Image source: Getty Images. Schedule this Last July, Insys Therapeutics gained approval from the Food and […]

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title,85,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary,iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://host.madison.com/business/investment/markets-and-stocks/gw-pharmaceuticals-biggest-win-in/article_75adaf4c-55a7-537e-855f-d78c7b0c9cbd.html

by